Valspring Capital led a $20m Series B round in Koala Health.

Valspring Capital, a Boston-based growth equity firm, led a $20m Series B round in Koala Health, a pet health company. “Koala Health is redefining the pet prescription experience by building a seamless bridge between veterinarians and pet parents. By partnering directly with clinics and making it easier for pet owners to manage medications, Koala is creating a smarter, more efficient ecosystem that benefits everyone involved. It’s a modern solution to a long-overdue problem in veterinary care,” Yumin Choi, Valspring Capital Co-founder & Managing Partner.